Apple’s latest wearable models—the Apple Watch Series 12 and Ultra 4—introduce upgraded health sensors, but for some users the launch comes with drawbacks. In over 30 nations, “Hypertension Notifications,” a feature that alerts users to sustained high blood pressure readings, may be unavailable when the devices go on sale. Regulatory clearance is still pending in those regions.
What’s Changing
The new watches feature a redesigned health sensing system. Although the devices bring enhanced optical and electrical heart sensors expected to boost measurement accuracy, these changes require fresh regulatory approvals. That means countries that previously offered hypertension alerts could lose access until the authorities greenlight the revised hardware and software.
Notable sensor upgrades include larger electrodes for improved skin contact during ECG readings, optimized photodiodes arranged in a ring layout for better light capture, and energy-efficient green LEDs enabling heart rate detection every five seconds. Health metrics like heart rate variability (HRV) will be tracked as often as every five minutes, and real‐time heart rate will be available in the updated Heart Rate app. Move and Exercise activity rings will also become more accurate thanks to these enhancements.
Where It Matters
The interruption to hypertension alerts affects users in countries like Canada, Australia, India, Brazil, Singapore, Japan, Taiwan, South Africa, South Korea, and the UAE. A full list is available on Apple’s region-by-region feature availability page. In regions outside of that list—including the United States, the United Kingdom, and all European Union member states—the alerts will continue uninterrupted.
For users who already receive these notifications on earlier Apple Watch models, upgrading to Series 12 or Ultra 4 could mean losing the feature temporarily in those affected regions. Apple confirms this adjustment is tied to the ongoing regulatory clearance process, and expects the notifications to resume once approval is secured.
These developments come alongside Apple’s annual hardware refresh. The Series 12 and Ultra 4 arrive with several new tech features, but this is the first time Hypertension Notifications—introduced under watchOS 26—face such widespread regional disruption due to sensor redesigns.
This situation underscores how health tech is not just about innovation—it’s also about navigating global regulation. For users in affected countries, this lapse could create gaps in monitoring critical health data. Apple will need efficient regulatory work to restore full feature availability, which will be closely watched. Meanwhile, the shift highlights the growing tension between improving sensor accuracy and adhering to regional medical device laws. Future updates, both hardware and firmware, could determine how seamlessly users transition and regain access to capabilities they’ve come to rely on.
